|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
FY2021
12 months to Mar 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Operating costs and expenses: | |||||
| Cost of sales (exclusive of depreciation shown separately below) | |||||
| Selling, general and administrative | |||||
| Depreciation and amortization | |||||
| Legal contingencies loss | |||||
| Restructuring | |||||
| Loss (gain) on sale of assets and businesses, net | |||||
| Operating Expenses | |||||
| Operating income | |||||
| Non-service defined benefit expense (income) | |||||
| Debt modification and extinguishment loss | |||||
| Warrant remeasurement gain, net | |||||
| Interest expense and other, net | |||||
| Income (loss) from continuing operations before income taxes | |||||
| Income tax expense | |||||
| Income (loss) from continuing operations | |||||
| Income from discontinued operations, net of tax expense of $0, $11,788 and $2,728, respectively | |||||
| Net income | |||||
| Earnings (loss) per share-basic: | |||||
| Earnings (loss) per share - continuing operations | |||||
| Earnings per share - discontinued operations | |||||
| Earnings per share | |||||
| Weighted average common shares outstanding—basic | |||||
| Earnings (loss) per share-diluted: | |||||
| Earnings (loss) per share - continuing operations | |||||
| Earnings per share - discontinued operations | |||||
| Earnings per share | |||||
| Weighted average common shares outstanding—diluted | |||||
Loading...
